Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

RTTNews | 875 hari yang lalu
Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

The European Commission is expected to announce a final decision in the coming months. FL and DLBCL are the two most common subtypes of B-cell non-Hodgkin lymphoma (B-NHL).

The positive CHMP opinion is supported by results from the Phase 1 ELM-1 and pivotal Phase 2 ELM-2 trials, which demonstrated robust, durable response rates and an acceptable safety profile of odronextamab in adults with R/R FL or R/R DLBCL. The EMA previously granted odronextamab Orphan Designation for both FL and DLBCL. Odronextamab is currently under clinical development and has not been approved by any regulatory authority.

Regeneron continues to evaluate the use of odronextamab as a monotherapy and in combination across earlier lines of therapy in challenging-to-treat lymphomas.

baca selengkapnya
Regeneron Pharma Q2 Results Top Estimates - Update

Regeneron Pharma Q2 Results Top Estimates - Update

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) reported on Thursday that net income for the second quarter increased to $1.43 billion or $12.41 per share from $968 million or $8.50 per share in the prior-year quarter.
RTTNews | 841 hari yang lalu
Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.
RTTNews | 1022 hari yang lalu
Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.
RTTNews | 1603 hari yang lalu
Swiss Market Ends Weak For 4th Straight Session

Swiss Market Ends Weak For 4th Straight Session

The Switzerland market ended weak on Friday, extending recent losses, as rising uncertainty about AI trade and rising cost of debts, as well as fears of possible interest rate hikes by central banks rendered the mood bearish.
RTTNews | 2 jam 27 menit yang lalu
European Markets Close Notably Lower As AI Trade Concerns Trigger Sell-off

European Markets Close Notably Lower As AI Trade Concerns Trigger Sell-off

European stocks fell on Friday and several markets across the region hit multi-week lows - some markets even dropped to multi-month lows - weighed down by losses in several sectors, especially in the technology space amid uncertainty about the sustainability of AI trade despite Anthropic's historic IPO.
RTTNews | 2 jam 54 menit yang lalu
TSX Sinks To 6-Month Low As Tech Sector Crumbles

TSX Sinks To 6-Month Low As Tech Sector Crumbles

Canadian equities tumbled Friday as technology stocks plunged 4.4% following global AI trade concerns. The benchmark index dropped 418.25 points to 33,610.48. Materials and financial sectors also declined significantly on weak commodity prices.
RTTNews | 3 jam 44 menit yang lalu
U.S. Consumer Sentiment Improves More Than Previously Estimated November

U.S. Consumer Sentiment Improves More Than Previously Estimated November

A report released by the University of Michigan on Friday showed consumer sentiment in the U.S. improved by more than previously estimated in the month of November. The University of Michigan said its consumer sentiment index for November was upwardly revised to 51.5 from a preliminary reading of 51.0.
RTTNews | 5 jam 25 menit yang lalu